Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the "Repla
(Financial Post, 2025-12-12T21:55:48Z)